Natasha Leskovsek

Of Counsel
Full contact info

I’ve taken my clinical and consulting experience for pharma and biotech companies on regulatory issues and brought them to Cooley’s clients.

Passions

Providing practical compliance solutions at the intersection of science and regulation

Experience

Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie

June 30, 2025

Cooley advised Capstan Therapeutics, a clinical-stage biotechnology company with a mission to multiply therapeutic possibilities for patients through targeted in vivo RNA technologies, on its definitive agreement to be acquired by AbbVie.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Ken Rollins
Partner in Charge – San Diego, San Diego
Edmond Lay
Partner, San Diego
Charity Williams
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
W. Chad Shear
Partner, San Diego
Jeffrey J. Tolin
Partner, New York
Stacey A. Bradford
Special Counsel, Washington, DC
Chen Chen
Special Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Rachel Thorn
Of counsel, New York
Alexandria Ashour
Associate, San Diego
Navya Dasari
Associate, New York
Joshua Elefant
Associate, Palo Alto
Tony P. Guan
Associate, Santa Monica
Michelle Hunt
Associate
Emily Mok
Associate, Reston
Jonathan Perez-Reyzin
Associate, San Diego
Breanna Qin
Associate, Palo Alto
David D. Suh
Associate
Christopher Suhler
Associate, Colorado
Novak Topalovic
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Rubin Waranch
Associate, Colorado
Yuhan Wu
Associate, Palo Alto
Joanna Zhang
Associate, San Diego
Jessica Wade
Paralegal Specialist, San Diego

Related Practices & Industries

Otsuka Pharmaceutical Announces Global Strategic Collaboration With Harbour BioMed

June 23, 2025

Cooley advised Otsuka Pharmaceutical, a total healthcare company focused on each individual’s potential to enhance their well-being, on its global strategic collaboration with Harbour BioMed to advance BCMAxCD3 bispecific T-cell engagers for treating autoimmune diseases.

Read more

Related contacts

Jennifer Raab
Partner, Palo Alto
Alison Freeman-Gleason
Of Counsel, Seattle
Rachel Thorn
Of counsel, New York
Zack Gong
Associate, Shanghai
Freddy Yip
Associate, Hong Kong
Jonathan Kaufman
Associate, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Yinan Lin
Associate, Palo Alto
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Caris Life Sciences Announces $494 Million IPO

June 20, 2025

Cooley advised the underwriters of Caris Life Sciences, a patient-centric, next-generation artificial intelligence techbio company and precision medicine pioneer, in connection with Caris’ $494 million initial public offering (IPO).

Related contacts

Eric Blanchard
Partner, Boston
Div Gupta
Partner, New York
Charlie Kim
Partner, San Diego
Minkyu Park
Special Counsel, New York
Mark Ballantyne
Partner, Reston
Ariane A. Andrade
Partner, Chicago
Shamis Beckley
Partner, Boston
Caitlin Courtney
Partner, Palo Alto
Annie Froehlich
Partner, Washington, DC
Daniel Grooms
Partner, Washington, DC
Jonie Ing Kondracki
Partner, San Francisco
Phil Mitchell
Partner, New York
Sonia Nath
Partner, Washington, DC
Gerard O'Shea
Partner, New York
Tracy Rubin
Partner, Palo Alto
Francis Wheeler
Senior Counsel, Colorado
Son Nguyen
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
William Corcoran
Of Counsel, Boston
Natasha Leskovsek
Of Counsel, Washington, DC
Trevor Bossi
Associate, Boston
Cara Buchicchio
Associate, New York
Eric J. Delgado
Associate, New York
Matthew Iannone
Associate, New York
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Calvin Lee
Associate, New York
Amiti C. Rothstein
Associate, New York
Dr. Jason Valentine
Associate, Washington, DC
Margaux Arntson
Associate

Related Practices & Industries

Philochem AG Announces up to $1.35 Billion License Agreement With RayzeBio

June 10, 2025

Cooley advised Philochem AG, a wholly owned subsidiary of the Philogen Group (Milan Stock Exchange: PHIL), on its definitive license agreement with RayzeBio, a wholly owned subsidiary of Bristol Myers Squibb (NYSE: BMY), granting RayzeBio exclusive worldwide rights to develop, manufacture and commercialize OncoACP3, a clinical-stage therapeutic and diagnostic agent targeting prostate cancer.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Joe Sandys
Special Counsel, London
Alexandra Paterson
Associate, London
Joseph Perry
Associate, Reston
J. Brian Stalter
Special Counsel, New York
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Megan Browdie
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Ann Bevitt
Partner, London
Rachel Thorn
Of counsel, New York
Dr. Jon Cousin
Partner, Washington, DC

Related Practices & Industries

BioNTech Announces Global Collaboration Agreement With Bristol Myers Squibb

June 3, 2025

Cooley advised BioNTech SE, a global biotechnology company pioneering next-generation immunotherapies, on its global co-development and co-commercialization collaboration agreement with Bristol Myers Squibb for BioNTech’s antibody candidate BNT327. The transaction includes a $1.5 billion upfront payment and $2 billion total in noncontingent anniversary payments through 2028.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
J. Brian Stalter
Special Counsel, New York
John Forrest
Associate, Boston
Arda Can Tekin
Associate, New York
Megan Browdie
Partner, Washington, DC
David Burns
Special Counsel, Washington, DC
Jonas Koponen
Partner, Brussels
Rachel Thorn
Of counsel, New York
Eric Blanchard
Partner, Boston
Christopher Kimball
Partner, Washington, DC
Joe Sandys
Special Counsel, London
Natasha Leskovsek
Of Counsel, Washington, DC
Navya Dasari
Associate, New York
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

View more

Admissions and credentials

District of Columbia

Maryland

Memberships and affiliations

Food and Drug Law Institute